作者
Cathy McShane,Rachel Varley,Anne Fennessy,Clodagh Byron,John Richard Campion,Karl Hazel,Conor Costigan,Eabha Ring,Alan Marrinan,Ciaran Judge,K Sugrue,Garret Cullen,Cara Dunne,Karen Hartery,Marietta Iacucci,Orlaith Kelly,J Leyden,Susan McKiernan,Aoibhlinn O’Toole,Juliette Sheridan,Eoin Slattery,Karen Boland,Deirdre McNamara,Laurence J. Egan,Subrata Ghosh,Glen A. Doherty,Jane McCarthy,David Kevans
摘要
A significant proportion of inflammatory bowel disease (IBD) patients fail to respond to advanced therapies. Combining advanced therapies may improve treatment outcome. This study aimed to assess the effectiveness, adverse events, and costs associated with combining advanced therapies in IBD patients.